Health and Healthcare

Health and Healthcare Articles

Medicines Co shares shot up on Monday after it was reported that Novartis will be acquiring the firm. The transaction was unanimously approved by the boards of directors of both companies.
Aquestive Therapeutics shares jumped on Monday after the firm announced that its treatment of amyotrophic lateral sclerosis (ALS), Exservan, received early-action approval from the U.S. Food and Drug...
Iovance Bio announced results from a subgroup analysis of metastatic melanoma patients in its Phase 2 study of lifileucel.
ProQR Therapeutics shares jumped early on Thursday after the firm announced that it received an approval from the FDA for its autosomal dominant retinitis pigmentosa drug.
Aravive shares skyrocketed on Wednesday after the firm announced early-stage data for its ovarian cancer treatment.
Kiniksa Pharma shares jumped on Wednesday after the firm announced that the FDA granted Breakthrough Therapy designation for rilonacept for the treatment of recurrent pericarditis.
Karuna Therapeutics shares skyrocketed on Monday after the firm announced mid-stage results from its schizophrenia treatment. Now shares are on the move again after Karuna said that it would be...
Myovant Sciences shares more than doubled on Tuesday after the firm announced results from its Phase 3 Hero study of relugolix for prostate cancer.
Medicines shares shot up on Tuesday after it was reported that Novartis might be eyeing this company as its newest acquisition.
The unhealthiest state in the union, according to statistics compiled by LetsGetChecked, a home health and wellness testing site, is West Virginia. The healthiest state by the same metrics is Utah....
On top of the potential game-changer for schizophrenia patients, some Karuna Therapeutics investors just experienced the same euphoria as holding a winning lottery ticket.
Here are five health-care-related stocks that recently saw their 50-day moving average cross above the 200-day average, a golden cross.
Cybercrime against health care organizations is rising and it is not only costing the victims money, it lowers their quality of care for years after.
There is a huge risk-reward factor in emerging pharmaceutical and biotech companies that happen to have all their eggs in just one basket. That's the case of resTORbio.
AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.